CVS Health $CVS showed investors solid work on turning the company around — for the fourth time this year it raised its profit and revenue outlook for 2025 and confirmed that the consolidation efforts of new CEO David Joyner are delivering results. Earnings per share are expected to reach 6.60–6.70 USD, which is slightly above consensus, and revenue is expected to exceed 400... Zobrazit více
If it can grow at an 18% CAGR over the next 3–5 years, that’s not bad at all. I just don’t know how they plan to achieve that, and I don’t follow it at all, so I have no idea what’s changed there in the few years it’s been sideways.
Bulios Black
Tento uživatel má díky předplatnému přístup k exkluzivnímu obsahu, nástrojům a funkcím.
If it can grow at an 18% CAGR over the next 3–5 years, that’s not bad at all. I just don’t know how they plan to achieve that, and I don’t follow it at all, so I have no idea what’s changed there in the few years it’s been sideways.